Friday May 17
Stopping Phentermine After Long-Term Treatment Does Not Result In Amphetamine-Like Withdrawal
New research published at the European Congress on Obesity shows that abrupt cessation after long-term use of the anti-obesity drug phentermine does not induce amphetamine-like withdrawal symptoms.
Sat May 11, 2013
Why Does Arena's Obesity Drug Have Abuse Potential?
Lorcaserin, brand name Belviq , is conditionally approved in the U.S. for chronic weight management in obese or overweight adults when used together with a reduced-calorie diet and exercise.
Thu May 09, 2013
New Website Offers Information on Phentermine 37.5MG for Weight Loss
One of the most prescribed diet pills in America today, Phentermine 37.5 diet pill is used as part of a short-term plan, typically 3-6 months, in conjunction with a low calorie diet and moderate activity, for weight reduction.
Mon May 06, 2013
Arena And Vivus Weaken On Poor Obesity Drug Prospects In Europe
Responding to news that the company would withdraw its MAA for Belviq from the EMA, shares of Arena Pharmaceuticals tanked by 9.2% last Friday as investors questioned whether obesity drugs had a future in the EU market.
Mon Apr 22, 2013
Former Pulaski doctor fined for improperly dispensing diet drug
A former Pulaski doctor has been fined by the Virginia Board of Medicine for dispensing a diet drug without proper licensure.